Stelara® (ustekinumab) data shows accordant safety for disease of the skin patients Pharmacy continent New findings conferred today from pooled analyses of the ongoing STELARA®▼ (ustekinumab) psoriasis clinical development programme showed that the safety profile of ustekinumab and rates of inauspicious events remained accordant and stable concluded time in ... and more » Link To Article
No comments:
Post a Comment